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CRITICAL ROLE OF CD13/AMINOPEPTIDASE N IN BONE/CARTILAGE
COMMUNICATION IN OSTEOARTHRITIS: ABILITY TO BIND 14-3-3E
M. Neﬂa, Jr. y, L. Sudre, Jr. y, F. Berenbaum, Sr. z,x, C. Jacques, Sr. y,x. yUniv.
Pierre et Marie Curie e INSERM UMR S938, Paris, France; zUniv. Pierre et
Marie Curie e INSERM UMR S938- DHU i2B, Paris, France; xAP-HP, Ho^pital
Saint-Antoine, Paris, France; kDHUi2B, Paris, France
Purpose: Osteoarthritis (OA) is a whole-joint disease characterized by
progressive destruction of articular cartilage which involves the three
joint tissues (subchondral bone, articular cartilage and synovial mem-
brane). Our team identiﬁed 14-3-3ε as a novel soluble mediator critical
in the communication between subchondral bone and cartilage in OA.
This protein acts as a potent MMP-3 and MMP-13-stimulatory factor in
chondrocytes leading to catabolic phenotype. CD13/APN, potential
receptor of this protein, was identiﬁed on the surface of chondrocytes
suggesting its role in bone/cartilage communication.
Methods: Experiments were performed from murine cartilage of the
C57BL/6J mice (5-6 days old), and from human cartilage samples,
obtained from OA patients undergoing total joint replacement surgery
for OA. CD13/APNwas invalidated by siRNA inmurine chondrocytes and
blocked with anti-CD13 monoclonal antibodies in murine and human
chondrocytes and then stimulated by 14-3-3ε. Chondrocyte gene
expression and release of MMP-3 andMMP-13was evaluated by RT-PCR
and western-blotting or ELISA. Aminopeptidase N activity in murine
and human chondrocytes was assessed in supernatant using the ﬂuo-
rescent substrate L-alanine B-naphtilamide. Interaction between 14-3-
3ε and CD13/APN was measured using surface Plasmon Resonance
(SPR) on a Biacore 3000 instrument.
Results: Invalidation of CD13/APN by siRNA or blocking antibody in
articular chondrocytes reduced signiﬁcantly mRNA expression andprotein release of MMP-3 and MMP-13 induced by 14-3-3ε. Amino-
peptidase N activity was identiﬁed in murine and human chondrocytes.
Treatment with APNi (Speciﬁc inhibitor of Aminopeptidase N) inhibited
strongly this activity. However, Aminopeptidase N was unchanged fol-
lowing stimulation with 14-3-3ε. Thus, these results suggest that CD13/
APN is involved in 14-3-3ε signal transduction and establishement of
procatabolic phenotype in murine and human articular chondrocytes,
independently of its enzymatic activity. Finally, human recombinant
CD13/APN was covalently immobilized on CM5 chip. An IgG1 isotype, a
speciﬁc blocking antibody of human CD13 and human recombinant 14-
3-3e were used as analytes. Results showed a direct interaction between
recombinant CD13/APN and 14-3-3ε (78 RU), a higher binding with
blocking antibody (170 RU) and no binding with IgG1 isotype (00 RU).
Kinetic tests were performed then using increasing concentrations of
recombinant 14-3-3ε and showed that 14-3-3ε has a lowafﬁnity to CD13/
APN with a dissociation constant (KD) of 2.45 x 10-6 M and a c2 value of
2.09 showing a good ﬁt. These results suggest that CD13/APN interacts
directly with extracellular 14-3-3ε to transmit its signal in chondrocytes.
Thus, our results seem designate 14-3-3ε and CD13 as novel proteins to
be explored in OA, either for therapeutic or prognostic purposes.
Conclusions: Our current data allowed to have a better understanding
on mechanism of action of 14-3-3ε, and especially on its signalling
pathways. Thus, this protein could be considered as a new target for
treatment of OA by its interaction with CD13/APN and provide data to
go further on preclinical step.
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ANALYSIS OF SINGLE ANION CHANNEL ACTIVITY IN CHONDROCYTES
IN VITRO
K. Kumagai y, F. Toyoda z, T. Maeda z, H. Tanigawa z, A. Mobasheri x,
R. Barrett-Jolley y. yUniv. of Liverpool, Liverpool, United Kingdom; z Shiga
Univ. of Med. Sci., Shiga, Japan; xUniv. of Surrey, Guilford, United Kingdom
Purpose: Once osteoarthritis (OA) has progressed it is difﬁcult to treat
with drugs and frequently an operation (such as joint arthroplasty and
autograft with arthroscopy) is required. Both of these options provide
only symptomatic treatment and there are no effective cures. Therefore,
elucidation of physiological function and construction of detailed car-
tilage models, including chondrocyte homeostatic maintenance mech-
anisms may facilitate future OA preventative treatments.
It is clear that mechanical activity of joints couples to chondrocyte
metabolic activity, but the role of this coupling in OA is unknown. A
simple way to mechanically disturb chondrocytes whilst simultaneously
making electrophysiological recordings from chondrocytes is to use
osmotic shock. In our previous chondrocyte electrophysiological work
we have analyzed changes of both cation and anion channel activity in
response to osmotic changes. In our recent anion work, we used whole-
cell experiments to show that a volume-sensitive Cl- current (ICl,vol) is
functionally expressed in rabbit articular chondrocytes and is activated
by membrane stretch induced by hyposmotic solutions. Recently, it has
also been suggested that aberrant activation of ICl,vol under isosmotic
condition contributes to the cell shrinkage and apoptosis (apoptotic
volume decrease, AVD) in various cell types including chondrocytes. We
showed that various blockers of ICl,vol prevented AVD and subsequent
cell death induced by ischemia-reperfusion stress or apoptotic inducers
such as doxorubicin, Fas-ligand and TNF-a. The levels of several pro-
inﬂammatory cytokines are elevated in osteoarthritis, and so the present
study aimed to investigate the effects of inﬂammatory cytokines on
functional expression of anion channels in chondrocytes.
Methods: Canine cartilage was collected from the stiﬂe and elbow joints
and isolated with type-II collagenase as reported previously (animals
euthanized for unassociated veterinary reasons). Electrophysiological
studies were carried out using up to 3rd passage canine chondrocytes
Cytokine treatment was 72hrs TNF-a and IL-1b 1ng/ml each. Single-
channel activity was recorded using cell-attached patch clamp of isolated
chondrocytes (pipette solution containing 115/ 28mM (KG/KCl).
Results: Single-channel analyses of both normal (control) and cytokine
treated canine chondrocytes show the presence of a large number of
phenotypically distinct ion channels upon hypo-osmotic shock. In this
study we selected for analysis, only ion channels with reversal poten-
tials near to the predicted equilibrium potential for chloride (approx-
imately þ20mV under these recording conditions). We analyzed a total
of 18 patches including 9 cytokine treated and 9 untreated. In untreated
patches, 3/9 exhibited clear channel activity reversing near to ECl-
(“chloride-like” channels) and the mean slope unitary conductance for
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proportion of patches exhibiting chloride-like ion channel activity was
similar (4/9), however this included two conductance populations; one
similar to that seen under control conditions (87±19pS, n¼3), but also a
population of anion channels with signiﬁcantly greater unitary slope
conductances (214±39pS, p<0.05 n¼3).
Conclusions: In this simple model of inﬂammatory OA we have dis-
covered that an additional phenotype of ion channel becomes evident
following cytokine treatment, this is previously unreported at the single
channel level. The identity of these molecular markers is currently
unknown and future experiments will use a combination of physio-
logical, pharmacological andmolecular biological techniques to identify
putative changes in underlying anion channel gene expression.
Funding: The research leading to these results has receivedpartial funding
from the European Union Seventh Framework Programme (FP7/2007-
2013) under grant agreement number 305815 and the Royal Society.
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THE ROLE OF LIVER X RECEPTOR IN CHONDROCYTE
DIFFERENTIATION AND OSTEOARTHRITIS
M.-G. Sun, F. Beier. Univ. of Western Ontario, London, ON, Canada
Purpose: Activation of the Liver X Receptor (LXR) has recently been
identiﬁed as a potential therapeutic strategy for osteoarthritis (OA). In
particular, recent studies report that human OA articular cartilage
explants show decreased LXR expression, and LXRb-null mice display
OA-like symptoms. Additionally, LXR agonist administration to OA
articular cartilage explants suppresses proteoglycan degradation and
restores LXR-activated transcription. We investigate the effect of LXR
activation on chondrocyte differentiation to elucidate the molecular
mechanisms behind its protection against OA.
Methods: The speciﬁc LXR agonist, GW3965, was used to examine the
effect of LXR activation on chondrocyte differentiation. Tibia organ
cultures were used to examine the effect of LXR activation on bone
growth and growth plate morphology, followed by immunohis-
tochemical analysis. In ATDC5 and micromass cultures, chondrocyte
differentiation was examined through cellular staining and pro-
liferation assays. Various chondrogenic markers were analyzed through
qRT-PCR in micromass cultures. Affymetrix microarray analyses were
performed on primary mouse chondrocytes to examine differential
gene expression in response to GW3965 treatment.
Results: Chondrocyte hypertrophy was suppressed by GW3965 treat-
ment, as shown by decreased hypertrophic zone length in the tibia
growth plate, decreased alkaline phosphatase staining in ATDC5 and
micromass cultures, and down-regulation of Col10a1, Mmp13 and
Runx2 expression. Increased proliferation in treated ATDC5 cells, up-
regulation of Col2a1 expression in treated micromass cultures and
decreased p57 levels in treated growth plates suggest hypertrophy is
suppressed secondary to delayed cell cycle exit. Interestingly, LXR
activation decreased alcian blue staining in micromass cultures. Various
genes controlling lipid homeostasis, such as Abca1, Abcg1, and Srebf1
were signiﬁcantly up-regulated at least 1.5 fold in primary mouse
chondrocytes after GW3965 treatment in comparison to DMSO control.
Conclusions: Our ﬁndings demonstrate LXR activation in chondrocytes
suppresses chondrocyte hypertrophy in-vitro through cell-cycle exit
delay and retention of proliferation. Signiﬁcant up-regulation of lipid
homeostasis genes in response to GW3965 treatment suggests LXR
regulation of chondrogenic genes to be secondary to changes in lipid
metabolism. These studies on cartilage development provide insight
into how LXR activation prevents cartilage breakdown, further solid-
ifying its potential as a therapeutic target of OA.
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DISTINCT EXPRESSION OF SREBP-2 IN NORMAL AND
OSTEOARTHRITIC CHONDROCYTES
K. Tao, Sr. y,z, X. Tang y, B. Wang y, J.R. Li y, L. Jiang y, H.J. Lin y. y Peking
Univ. People's Hosp., Beijing, China; z Peking Univ. Hlth.Sci. Ctr., Beijing,
China
Purpose: Recent reports have elucidated that osteoarthritis (OA) is a
metabolic disease with the epigenetic and proteomic analysis studies for
various lipid metabolism-related genes and proteins comparing osteo-
arthritic cartilage with normal. Sterol regulatory element-binding protein
2 (SREBP2) is a ubiquitously expressed transcription factor that controlscholesterol homeostasis by stimulating transcription of sterol-regulated
genes, such as 3-hydroxy-3-methyl glutaryl CoA reductase (HMGCR) [1].
Apart from regulating cholesterol homeostasis, several studies have pro-
vided evidence that SREBP2 and its various single nucleotide poly-
morphisms (SNPs) also play an central role in the pathogenesis of
osteoarthritis, however, the association of SREBP2 with articular chon-
drocytes arthritogenic effects of IL-1beta (IL-1b) has been poorly under-
stood [2, 3]. In this study, we investigated the association between SREBP2
expression and IL-1b-induced articular chondrocytes arthritogenic effects.
Methods: Human cartilage were obtained from total knee arthroplasty
for osteoarthritis or total hip arthroplasty for fracture of neck of femur
(normal control group). Meanwhile, the normal and osteoarthritic carti-
lage isolated from of C57BL/6 mice and surgically induced osteoarthritis
models. Then, immunohistochemistry staining and quantitative real-
time polymerase chain reaction (qRT-PCR) were performed to detect the
expression of SREBP2,HMGCR, SOX9, type II collagen and typeX collagen.
Moreover, we treated normal chondrocytes with different concentration
of IL-1b, and examined the expression of the above genes.
Results:We found that the expression of SREBP-2, HMGCR, SOX9, type
II collagen and type X collagen in OA patients and normal controls were
signiﬁcantly different, and similar results obtained in the two C57BL/6
mice groups. After induced by IL-1b, normal chondrocytes turned
hypertrophy-like chondrocytes, and notably, the expression of SREBP-2,
type X collagen and HMGCR were upregulated, and SOX9 and type II
collagen were suppressed in vitro.
Conclusions: These data suggest that SREBP-2 has a distinct expression
in normal and osteoarthritic chondrocytes. Proinﬂammatory cytokine
IL-1b may inﬂuence the hypertrophy and function of chondrocyte in
part through SREBP-2.
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MITOCHONDRIA: A NEW CHONDROITIN SULPHATE THERAPEUTIC
TARGET FOR OSTEOARTHRITIS
V. Calamia, Sr. y, M. Lopez-Armada, Sr. y, E. Montell, Sr. z, J. Verges, Sr. z,
C. Ruiz-Romero, Sr. y, F.J. Blanco, Sr. y. yUniv.e da Coru~na, A Coru~na,
Spain; z Pre-Clinical R&D Area, Bioiberica, Barcelona, Spain
Purpose: In a recent proteomic study, we have demonstrated that
mitochondrial dysregulation occurs in cartilage cells during osteo-
arthritis (OA). These ﬁndings suggest that mitochondriarepresent an
attractive target for anti-OA pharmacotherapy. In this study we have
investigated the mitochondrial activity of OA human articular chon-
drocytes treated with chondroitinsulphate (CS).
Methods: Chondrocytes were released by enzymatic digestion from OA
human cartilages (n¼8). The study was approved by the local ethic com-
mittee (Galician). Once reached 80% conﬂuence, cellswere treatedwith CS
(Bioiberica, Spain) inpresence or absenceof different stimuli (IL1b5ng/ml,
TNFa 10 ng/ml and LPS 100mg/ml). Cells were analyzed by ﬂow cytometry
tomeasure themitochondrialmembrane potential (Djm)using the probe
JC-1 (10 mg/ml) and to evaluate the intracellular production of ROS using
the dye DCFH-DA (10 mM). ATP Bioluminiscence Assay Kit (PerkinElmer)
was utilized to measure the production of intracellular ATP. A commercial
colorimetric assay kit (Sigma) was used to speciﬁcally quantify mito-
chondrial superoxide dismutase activity (SOD2).NOreleasewasmeasured
as nitrite concentration in 48 h culture supernatants by using the Griess
assay. SPSS statistical software was used to determine statistical sig-
niﬁcance by using U-Mann Whitney test (p  0.05).
Results: At basal condition, a 64% increase in chondrocytes Djm was
observed after 48 hours treatment with CS 200 mg/mL. When chon-
drocytes were stimulated with TNFa, a signiﬁcant depolarization was
induced (Djm decreased up to 41% and 39% respectively). Interestingly,
also in this case, CS was able to increase chondrocytes Djm up to 66%,
partially counteracting the effect of TNFa. To determine mitochondrial
function, we also assessed ATP production. Chondrocytes treatment with
